Its time to play Fool in the blank
News & Analysis: Dendreon Corp
Achillion, Receptos, and Dendreon could all make waves in biotech headlines this Tuesday morning.
Stocks with heavy short interest might signal that something is terribly wrong with a company. Dendreon Corp. sports one of the highest short interests among health-care stocks. Why are short-sellers so bearish on this small-cap biotech?
The stock market had a generally terrible day Tuesday, but these stocks still managed to post solid gains. Find out more about what made them soar.
Weak retail earnings and Fed commentary sink the S&P 500 as deal-making and clinical data releases sent these three stocks soaring.
Dendreon shares spike higher after presenting positive data on Provenge at the American Urological Association's annual meeting. Find out what investors should really be paying attention to instead.
Ophthotech, Dendreon, Edwards Lifesciences, and Medtronic could all loom large in health care headlines this Tuesday morning.
Stocks were mixed Thursday on a volatile day for the market. But these three stocks took big losses on the day. Find out why.
Denderon shareholders run for cover following the company's first-quarter earnings report. Is this dip a buying opportunity, or an omen to keep your distance?
Dendreon reported earnings before the opening bell today. Here's what investors need to know.